Chase C. Leavitt

Insider Reports History

Entity
Individual
Location
1010 Atlantic Avenue, Suite 102, Alameda, CA
Signature
/s/Chase C. Leavitt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chase C. Leavitt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. General Counsel/Secretary Common Stock 84.8K $42K $0.50 Jan 3, 2024 Direct
Oncternal Therapeutics, Inc. General Counsel/Secretary Stock Option 14.2K Feb 14, 2024 Direct

Insider Reports Filed by Chase C. Leavitt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCT Oncternal Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jan 3, 2024 1 -$5.87K 4 Jan 5, 2024 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Oct 2, 2023 9 $0 4 Oct 4, 2023 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jul 3, 2023 1 -$3.71K 4 Jul 5, 2023 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Apr 12, 2023 2 $7.25K 4 Apr 14, 2023 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jan 3, 2023 1 -$6.21K 4 Jan 5, 2023 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jan 27, 2022 2 $23.3K 4 Jan 31, 2022 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. Jun 11, 2021 1 $8.18K 4 Jun 15, 2021 General Counsel/Secretary
ONCT Oncternal Therapeutics, Inc. May 25, 2021 0 $0 3 May 27, 2021 General Counsel/Secretary